| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 47.6 | 51.3 | 49.9 |
| Other income | 3.7 | 0.3 | 0.7 |
| Total income | 51.3 | 51.7 | 50.7 |
| Profit before exceptional items & tax | 3.2 | 3.3 | 2.4 |
| Profit before tax | 3.2 | 3.3 | 2.4 |
| Net profit | 2.6 | 2.4 | 1.8 |
| Operating margin | 6.2% | 6.4% | 4.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +44.40% |
|---|---|
| Net profit, quarter on quarter | +8.30% |
| Revenue, year on year | -4.60% |
Source
Read the filing ↗
NSE results filing, NSE: VIJAYPD. Figures extracted from the filing.
VijayPD Ceutical Ltd: key numbers
- Share price
- ₹72.85
- Market cap
- ₹142.3 Cr
- Revenue (annual)
- ₹100.2 Cr
- Net profit (annual)
- ₹5.00 Cr
- P/E (TTM)
- 28.4×Sector 57.8×
- Promoter holding
- 56.43%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from VijayPD Ceutical Ltd
All →
13:05 IST
NSE
Partnership
VijayPD Ceutical Partnership
VijayPD Ceutical entered a Technical Business Collaboration with Acute Research Private Limited for pharmaceutical R&D and process development support. No contract value is disclosed.